COMMUNIQUÉS West-GlobeNewswire

Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
28/05/2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal [...]
PacBio to Present at Upcoming Investor Conferences
28/05/2025
MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the [...]
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
28/05/2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic [...]
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
28/05/2025
Regen Dog Chews are crafted to the highest quality standards, recommended by veterinarians and proven safe with no adverse effects reported in clinical trials LAS VEGAS, May 28, 2025 (GLOBE NEWSWIRE) -- via IBN -- [...]
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
28/05/2025
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
AI GPO Launches as Nation’s First AI-Focused Group Purchasing Organization, Democratizing Advanced AI Technology and Essential Business Savings
28/05/2025
ROCHESTER, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- AI GPO, the world’s first Group Purchasing Organization (GPO) singularly focused on Artificial Intelligence, today announced its national launch. The company is set to [...]
Intrommune Therapeutics Announces Independent Editorial Highlighting Breakthrough Safety Data for Novel Toothpaste Peanut Allergy Treatment
28/05/2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- As the burden of food allergies continues to increase each year, the need for safe, effective, and convenient treatments has never been greater. Over 33 million Americans [...]
What Causes Baldness? Everything You Need to Know About Hair Loss and Hair Growth Solutions.
28/05/2025
Are you starting to notice your hairline receding or more strands falling out than usual? You’re not alone. Hair loss is incredibly common—especially for men —and it often sparks questions like Boca Raton, FL, May 28, [...]
Local Neurosurgeon Jeremy Denning Raises Awareness for National Scoliosis Month
28/05/2025
Early Detection and Tailored Treatment Plans Can Improve Quality of Life PLANO, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- June is National Scoliosis Awareness Month – an ideal time to explore causes and treatment methods [...]
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3
28/05/2025
HOUSTON, TX, May 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on June 3, 2025, at 4:15 p.m. ET. Attendees will gain [...]
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
28/05/2025
PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released [...]
R1 Announces Investment from Khosla Ventures as it Accelerates AI-Driven Healthcare Transformation
28/05/2025
Investment Follows Recent R37 Launch MURRAY, Utah, May 28, 2025 (GLOBE NEWSWIRE) -- R1, an industry leader in managing and intelligently automating healthcare revenue management with over 20 years of experience, today [...]
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
28/05/2025
Target enrollment exceeded with 62 participants enrolled, including approximately 15 percent from U.S. sites Topline data is anticipated in December of 2025 REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- [...]
Vaxart Answers Additional Frequently Asked Questions from Retail Investors
28/05/2025
Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” OR [...]
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
28/05/2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with [...]
Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
28/05/2025
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will [...]
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
28/05/2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) ( CSE: BETR / OTCQB : BETRF / FRA: NPAU ), an emerging biotech company focused on the development of [...]
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
28/05/2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that [...]
Solid Biosciences to Participate at the Jefferies Global Healthcare Conference
28/05/2025
CHARLESTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]

Pages